Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J/Merck Pepcid Complete Combines H2 Antagonist/Antacid Ingredients

This article was originally published in The Tan Sheet

Executive Summary

J&J/Merck's Pepcid Complete is the first OTC stomach remedy to combine a fast-acting antacid ingredient with a long-term acid control ingredient, according to the firm. FDA approved NDA 20-958 for Pepcid Complete Oct. 16.
Advertisement

Related Content

Pepcid Complete Launch Backed By Extensive PR Campaign
Glaxo Zantac 75 Divestiture To W-L Required By FTC
Canadian Direct-To-OTC Sale Of Nicotine Inhaler Proposed
Pharmacia
Prilosec GERD Indication OTC Appropriateness Debated At NDAC Meeting
Prilosec GERD Indication OTC Appropriateness Debated At NDAC Meeting
Probiotic Infant Use Raises FDA, Food Advisory Committee Concern
McNeil
Benecol, Take Control Marketing Highlight Approved CHD Health Claims
J&J/Merck Pepcid AC Orally Disintegrating Tablets In The Works

Topics

Advertisement
UsernamePublicRestriction

Register

PS091796

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel